© 2020 Leon & Friends e.V. I Website by Philipp Apler
A Symposium about Syngap1 and Related Disorders
The Syngap1 Symposium 2021 brings together exceptional scientists from around the world with the incentive to advance Syngap1 research, build networks, stimulate collaboration and coordinate efforts.
15 – 16
MAR 2021
Due to the Covid 19 pandemic, this year’s symposium will take place over the internet.
What is Syngap1?
Syngap1 is a protein that is critical for the development of cognition and proper synapse function. Mutations in the Syngap1 gene lead to a rare neurodevelopmental disorder. Currently, about 400 children are diagnosed world-wide with this disease. Mutations in Syngap1 are associated with intellectual disability and are proposed to play a significant role in other diseases such as epilepsy, autism spectrum disorders and schizophrenias.
Our Mission
The non-profit organization Leon&friends e.V. is the main organizer of the Syngap1 Symposium and wants to inform the public and the scientific community about the disease and the current, high-class ongoing research. The idea is to bring together scientists to inform about recent developments in the research field, exchange ideas and present cutting-edge technologies that can be used for research on Syngap1.
About the Event
The Syngap1 Symposium 2021 will take place from March 15th to 16th. Due to the current pandemic, we’ve decided that this year’s event will take place online. The event’s public sessions can be attended free-of-charge (email registration required). Check out the schedule for a detailed overview on lectures and topics.
List of Speakers
Schedule
Time Zone: CET (UTC/GMT +1 hour)
- Monday, 15th March
- Tuesday, 16th March
| Header | |
|---|---|
|
13:45 - 14:00 |
Welcome address by EU commissioner Dr. Stella Kyriakides read by Verena Schmeder, first chairwoman Syngap Elternhilfe |
|
14:00 - 15:00 |
Keynote lecture 1: Gaia Novarino, Klosterneuburg, Austria: "Convergent molecular pathways in neurodevelopment disorders" (Chair: Frank Edenhofer) |
|
15:00 - 15:30 |
Vanja Nagy, Vienna, Austria: “Modeling intellectual disabilities in a dish: characterizing genetic pathophysiology in cell lines and primary cell cultures” (Chair: Frank Edenhofer) |
|
15:30 - 15:35 |
Break |
|
15:35 - 16:05 |
Michael Courtney, Turku, Finland: “Monitoring and manipulating plasticity-regulating neuronal signaling networks“ (Chair: Frank Edenhofer) |
|
16:05 - 16:35 |
Matthias Jung, Halle, Germany: “Modelling common pathways of Syngap1 syndrome and schizophrenia in human iPS cells.” (Chair: Frank Edenhofer) |
|
16:35 - 16:55 |
Discussion of preceding talks (Chair: Frank Edenhofer) |
|
16:55 - 17:00 |
Break |
|
17:00 - 17:30 |
Mimoun Azzouz, Sheffield, United Kingdom: „Prospects for gene therapeutics in neurological disorders“ (Chair: Vanja Nagy) |
|
17:30 - 18:00 |
Frank Edenhofer, Innsbruck, Austria: „Taking the short cut: induced neural stem cells in disease modeling and cell therapy" (Chair: Vanja Nagy) |
|
18:00 - 18:30 |
Maria Isabel Carreno Munoz, Montreal Quebec; "Sensory brain responses alterations as translational biomarkers for SYNGAP1 haploinsufficiency" (Chair: Vanja Nagy) |
|
18:30 - 19:00 |
Ryuichi Nakajima, Japan: "Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice" (Chair: Vanja Nagy) |
|
19:00 - 19:30 |
Discussion of preceding talks (Chair: Vanja Nagy) |
| Header | |
|---|---|
|
9:00 - 9:30 |
Alex Bayés, Barcelona, Spain : “A systems biology approach to elucidate the postsynaptic molecular alterations resulting from Syngap1 Deficiency“ (Chair: Winfried Neuhaus) |
|
9:30 - 10:00 |
Simon Hippenmeyer, Klosterneuburg, Austria: “Genetic Dissection of Neural Development in Health and Disease using Mosaic Analysis with Double Markers (MADM)” (Chair: Winfried Neuhaus) |
|
10:00 - 10:30 |
Noboru H. Komiyama, Edinburgh, UK: "SynGAP1 in NMDA receptor complex: Implications for development of therapeutic strategies for ASD." (Chair: Winfried Neuhaus) |
|
10:30 - 10:40 |
Break |
|
10:40 - 11:10 |
Eric Hosy, France: "Why organization of synaptic proteins at the nanoscale is essential for synaptic physiology?" (Chair: Winfried Neuhaus)
|
|
11:10 - 11:40 |
Discussion of preceding talks (Chair: Winfried Neuhaus)
|
|
11:40 - 13:00 |
Lunch Break |
|
13:00 - 14:50 |
Short talks (Chair: Matthias Jung) Schedule |
|
14:50 - 15:00 |
Break |
|
15:00 - 15:30 |
Marcelo Pablo Coba, USA: "SYNGAP1 signaling in mouse and human models" (Chair: Simon Hippenmeyer) |
|
15:30 - 16:00 |
Jimmy L. Holder, Texas USA: "Deep phenotyping in Syngap1-related disorder" (Chair: Simon Hippenmeyer) |
|
16:00 - 16:30 |
Prof. Kluger & Team: „Clinical aspects in SYNGAP1 and invitation for collaboration: project PATRE“ (Chair: Simon Hippenmeyer) |
|
16:30 - 16:55 |
Discussion of preceding talks (Chair: Simon Hippenmeyer) |
|
16:55 - 17:00 |
Break |
|
17:00 - 18:00 |
Keynote lecture 3: Richard Huganir: "Twenty years of SynGAP research: from Synapses to Cognition" (Chair: Gaia Novarino) |
|
18:00 - 20:00 |
Discussion on Gaps in Syngap research (Chair: Richard Huganir) |
Registration
Attendance to all lectures and sessions is free-of-charge, but restricted. Please send your registration to hallo@leonandfriends.org or use the form below until March 14th, 2021 with contact information and your attendance reason (e.g. pure scientific interest OR work in the field XY). You will receive an invitation link shortly before the event.
Registration Form
Organizer
Leon & Friends e.V.
The non-profit organization aims to support children who suffer from Syngap1 syndrome and to drive research for treatment methods.
Visit website I Donate here
Co-Organizers
AIT Austrian Institute of Technology
The AIT is Austria’s largest Research and Technology Organization (RTO), employing about 1,300 people.
Visit website
ANA Austrian Neuroscience Association
ANA provides a platform for Austrian Neuroscience and is amember of the Federation of European Neuroscience Societies (FENS).
Visit website
The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences is an interdisciplinary research institute committed to advancing the understanding of human diseases through basic and biomedical research.
Visit website
The Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases
The LBI-RUD has been founded to implement a coordinated research program on the genetic and functional basis of rare diseases.
Visit website
Co-Chairs
Winfried Neuhaus
AIT – Austrian Institute of Technology, Vienna
Sigismund Huck
Center for Brain Research, Vienna
Vanja Nagy
LBI Rare and Undiagnosed Diseases & CeMM, Vienna